INTELLIGENCE ENGINE ACTIVE
Loading market intelligence...
Synchronizing institutional flows, real-time analytics & intelligence models
Market Wisdom & Tenets
Value Investing“Price is what you pay. Value is what you get.”
Warren Buffett
+10
🤖 Claude MCP on paid plans — NSE/BSE data, screeners & research in Claude Desktop & Claude Code.
✨ Setup guideConnecting to market data…
Synchronizing institutional flows, real-time analytics & intelligence models
“Price is what you pay. Value is what you get.”
Aggregating institutional notes, consensus estimates & financial filings
“Price is what you pay. Value is what you get.”
Live intelligence from Upstox & official NSE regulatory filings (XBRL), with Yahoo / SEC fallbacks for US names.
BIOCON LIMITED.
₹364.05
Market closed · as of 00:57 IST · 14-11-2026
0 intraday points
Low
₹363.65
High
₹369.80
₹370.95
Previous close — your comparison point.
Down 1.86% from the previous close.
Data: Upstox
← Research home · Updated 11/13/2026, 7:27:30 PM
Checking what moves BIOCON…
Indian multinational biopharmaceutical company
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. Founded by Kiran Mazumdar-Shaw in 1978 as a partner to the Irish brewing enzyme manufacturer Biocon Biochemicals Ltd., the company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics, and branded drugs such as biosimilar insulins and antibodies for the Indian domestic market. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Source: WikipediaReading filings for BIOCON…